Vigl leads the allergy active immunotherapy project at AFFiRiS. He studied Biology with majors in Genetics and Immunology in Vienna and Leicester (UK). After his Diploma thesis in T cell signaling at the Medical University Vienna, he wrote his Doctoral thesis at the Pharmaceutical Institute of the Swiss Federal Institute of Technology (ETH) in Zurich about the influence of inflammation on lymphatic vessels and its impact on leukocyte trafficking. A related press release was awarded with the WISP prize 2011. In the same year he joined the company to bring the allergy active immunotherapy project from the early discovery to preclinical stage.